Strategic Choices in CAR T for Myeloma: Balancing Efficacy, Safety, and BCMA vs. GPRC5D Options

Opinion
Video

This video episode compares ide-cel and cilta-cel for patient selection, examining specific characteristics, efficacy and safety profiles, and their influence on treatment decisions across diverse patient groups.

Recent Videos
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content